NEW YORK (GenomeWeb News) – Microfluidic Systems yesterday said that it will use Applied Biosystems’ TaqMan assays in its Bioagent Autonomous Networked Detector for airborne pathogens.
 
Microfluidic Systems said that ABI will manufacture the assays, which can be used for detecting harmful pathogens. It noted that ABI’s TaqMan assays have provided more than 5.2 million anthrax screening tests through ongoing mail-screening applications.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.